Abstract:Obsessive Compulsive Disorder (OCD) is a debilitating psychiatric disorder characterized by intrusive obsessive thoughts and compulsive behaviors. Multiple studies have shown association of polymorphisms in the SLC1A1 gene with OCD. The most common of these OCD-associated polymorphisms increases expression of the encoded protein, Excitatory Amino Acid Transporter 3 (EAAT3), a neuronal glutamate transporter. Previous work has shown that increased EAAT3 expression results in OCD-relevant behavioral phenotypes in rodent models. In this study, we created a novel mouse model with targeted, reversible overexpression of Slc1a1 in forebrain neurons. These mice do not have a baseline difference in repetitive behavior but show increased hyperlocomotion following a low dose of amphetamine (3 mg/kg) and increased stereotypy following a high dose of amphetamine (8 mg/kg). We next characterized the effect of amphetamine on striatal cFos response and found that amphetamine increased cFos throughout the striatum in both control and Slc1a1 -overexpressing (OE) mice, but Slc1a1 -OE mice had increased cFos expression in the ventral striatum relative to controls. We used an unbiased machine classifier to robustly characterize the behavioral response to different doses of amphetamine and found a unique response to amphetamine in Slc1a1 -OE mice, relative to controls. Lastly, we found that the differences in striatal cFos expression in Slc1a1 -OE mice were driven by cFos expression specifically in D1 neurons, as Slc1a1 -OE mice had increased cFos in D1 ventral medial striatal neurons, implicating this region in the exaggerated behavioral response to amphetamine in Slc1a1 -OE mice. Significance statement Obsessive compulsive disorder is a debilitating psychiatric disorder with inadequate treatment options. The gene SLC1A1 has been associated with OCD in humans, and studies in rodents have shown alterations in OCD-relevant behavior and neural activity in mice with increased Slc1a1 expression. We created a novel mouse model with reversible forebrain overexpression of Slc1a1 and found that these mice show increased behavioral response to amphetamine. Using an unbiased machine classifier we found differences in clusters of amphetamine-induced behaviors in Slc1a1 -overexpressing mice. In addition, Slc1a1 -overexpressing mice showed increased neuronal activation in D1-expressing cells in ventromedial striatum following amphetamine administration. These results provide information about the role of Slc1a1 in repetitive behaviors and may contribute to novel treatments going forward.

Forebrain EAAT3 overexpression increases susceptibility to amphetamine-induced repetitive behaviors

Amphetamine-Induced OCD-Related Repetitive Behaviors Are Potentiated in Slc1a1-OE Mice

Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice

A novel role for E2F3b in regulating cocaine action in the prefrontal cortex

Cocaine-Induced Chromatin Modifications Associate with Increased Expression and Three-Dimensional Looping of Auts2.

Intact amphetamine-induced behavioral sensitization in mice with increased or decreased neuronal glutamate transporter SLC1A1/EAAT3

OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons

Compulsive Drug Use is Associated with Imbalance of Orbitofrontal- and Prelimbic-Striatal Circuits in Punishment-Resistant Individuals

Compulsive Drug-Taking is Associated with Habenula–frontal Cortex Connectivity

Persistent enhancement of basolateral amygdala-dorsomedial striatum synapses causes compulsive-like behaviors in mice

Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant

Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine

Time-dependent changes in striatal monoamine levels and gene expression following single and repeated amphetamine administration in rats

Severe drug-induced repetitive behaviors and striatal overexpression of VAChT in ChAT-ChR2-EYFP BAC transgenic mice

Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents

Acquisition and extinction of active avoidance compulsive-like behavior in mice

A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder

Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits

Viral over-expression of D1 dopamine receptors in the prefrontal cortex increase high-risk behaviors in adults: comparison with adolescents

Dopamine signaling in the dorsomedial striatum promotes compulsive behavior

loss drives striatal neuron hyperexcitability and behavioral inflexibility